VOR vs. NKE

In the year-to-date period, VOR achieves a -35.14% return, which is significantly lower than NKE's -23.47% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and NIKE, Inc. (NKE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VOR Sharpe Ratio is -0.60, which is higher than the NKE Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of VOR and NKE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VOR has not paid dividends to shareholders, while NKE's dividend yield for the trailing twelve months is around 2.67%.

The maximum VOR drawdown since its inception was -98.99%, which is greater than NKE's maximum drawdown of -68.53%. Use the drawdown chart below to compare losses from any high point for VOR and NKE. For additional features, visit the drawdowns tool.

Vor Biopharma Inc. (VOR) has a higher volatility of 27.97% compared to NIKE, Inc. (NKE) at 23.28%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than NKE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Vor Biopharma Inc. and NIKE, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.